INBX Inhibrx Biosciences, Inc.

Healthcare

$106.85+5.46%ClosedMarket Cap: $1.57B

As of 2026-05-26

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-6.53	$57.2M	1
Sun Dec 31	$-3.98	$131.3M	2
Mon Dec 31	$-2.73	$202.6M	1
Tue Dec 31	$2.76	$353.6M	1